Assessment of nasal pressure swing predicts respiratory support dependency in patients with hypoxic respiratory failure

IF 6.1 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL European Journal of Internal Medicine Pub Date : 2025-05-01 Epub Date: 2025-03-07 DOI:10.1016/j.ejim.2025.02.016
Roberto Tonelli , Giulia Bruzzi , Riccardo Fantini , Luca Tabbì , Antonio Moretti , Francesco Livrieri , Ivana Castaniere , Stefania Cerri , Daniele Puggioni , Federico Guidotti , Gianluca Bellesia , Alessandro Marchioni , Enrico Clini
{"title":"Assessment of nasal pressure swing predicts respiratory support dependency in patients with hypoxic respiratory failure","authors":"Roberto Tonelli ,&nbsp;Giulia Bruzzi ,&nbsp;Riccardo Fantini ,&nbsp;Luca Tabbì ,&nbsp;Antonio Moretti ,&nbsp;Francesco Livrieri ,&nbsp;Ivana Castaniere ,&nbsp;Stefania Cerri ,&nbsp;Daniele Puggioni ,&nbsp;Federico Guidotti ,&nbsp;Gianluca Bellesia ,&nbsp;Alessandro Marchioni ,&nbsp;Enrico Clini","doi":"10.1016/j.ejim.2025.02.016","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Monitoring is essential in managing acute hypoxemic respiratory failure (AHRF). Nasal pressure swing (P<sub>nose</sub>) may predict high-flow nasal oxygen (HFNO) therapy failure and respiratory support dependency. This study investigates P<sub>nose</sub>'s predictive value for respiratory support needs and clinical outcomes in AHRF patients initially treated with HFNO.</div></div><div><h3>Methods</h3><div>This post-hoc analysis included 60 AHRF patients treated with HFNO. Respiratory variables, including P<sub>nose</sub>, were assessed at baseline and two hours after HFNO initiation. Patients were classified into high (HG) and low (LG) Pnose groups based on a 5.1 cmH2O threshold. The primary outcome was RS-free survival at day 7; HFNO failure, escalation to non-invasive ventilation (NIV) or mechanical ventilation (MV), mortality, and HFNO weaning time were also analyzed. Predictive accuracy of respiratory indices, including P<sub>nose</sub>, was evaluated.</div></div><div><h3>Results</h3><div>Out of the patients enrolled, 35 were in the HG, and 25 in LG group. HG patients showed a lower RS-free survival at day 7 (adjusted HR=0.26, <em>p</em> &lt; 0.0001), and experienced higher failure rates of HFNO (88 % versus 0 %, <em>p</em> &lt; 0.0001), escalation to NIV (84 % versus 0 %, <em>p</em> &lt; 0.0001), endotracheal intubation (36 % versus 0 %, <em>p</em> &lt; 0.0001), and mortality (24 % versus 6 %, <em>p</em> = 0.0001) compared to LG. Accordingly, RS-free days at day 28 were lower in HG (11 days versus 23 days, <em>p</em> &lt; 0.0001). Finally, among the respiratory variables, P<sub>nose</sub> resulted independently associated with the primary outcome (OR=0.64 95 %CI [0.42–0.90], <em>p</em> = 0.02).</div></div><div><h3>Conclusions</h3><div>In patients with AHRF admitted to the ward and treated by HFNO, P<sub>nose</sub> is an independent and accurate factor in forecasting the dependency from RS and survival within the first week.</div></div>","PeriodicalId":50485,"journal":{"name":"European Journal of Internal Medicine","volume":"135 ","pages":"Pages 91-97"},"PeriodicalIF":6.1000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Internal Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0953620525000573","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Monitoring is essential in managing acute hypoxemic respiratory failure (AHRF). Nasal pressure swing (Pnose) may predict high-flow nasal oxygen (HFNO) therapy failure and respiratory support dependency. This study investigates Pnose's predictive value for respiratory support needs and clinical outcomes in AHRF patients initially treated with HFNO.

Methods

This post-hoc analysis included 60 AHRF patients treated with HFNO. Respiratory variables, including Pnose, were assessed at baseline and two hours after HFNO initiation. Patients were classified into high (HG) and low (LG) Pnose groups based on a 5.1 cmH2O threshold. The primary outcome was RS-free survival at day 7; HFNO failure, escalation to non-invasive ventilation (NIV) or mechanical ventilation (MV), mortality, and HFNO weaning time were also analyzed. Predictive accuracy of respiratory indices, including Pnose, was evaluated.

Results

Out of the patients enrolled, 35 were in the HG, and 25 in LG group. HG patients showed a lower RS-free survival at day 7 (adjusted HR=0.26, p < 0.0001), and experienced higher failure rates of HFNO (88 % versus 0 %, p < 0.0001), escalation to NIV (84 % versus 0 %, p < 0.0001), endotracheal intubation (36 % versus 0 %, p < 0.0001), and mortality (24 % versus 6 %, p = 0.0001) compared to LG. Accordingly, RS-free days at day 28 were lower in HG (11 days versus 23 days, p < 0.0001). Finally, among the respiratory variables, Pnose resulted independently associated with the primary outcome (OR=0.64 95 %CI [0.42–0.90], p = 0.02).

Conclusions

In patients with AHRF admitted to the ward and treated by HFNO, Pnose is an independent and accurate factor in forecasting the dependency from RS and survival within the first week.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
评估鼻压波动预测缺氧呼吸衰竭患者的呼吸支持依赖。
背景:监测是治疗急性低氧性呼吸衰竭(AHRF)必不可少的。鼻压波动(Pnose)可能预测高流量鼻氧(HFNO)治疗失败和呼吸支持依赖。本研究探讨了Pnose对AHRF患者呼吸支持需求和临床结果的预测价值。方法:对60例经HFNO治疗的AHRF患者进行事后分析。呼吸变量,包括Pnose,在基线和HFNO启动后2小时进行评估。根据5.1 cmH2O阈值将患者分为高(HG)和低(LG) Pnose组。主要终点为第7天无rs生存期;分析了HFNO故障、升级为无创通气(NIV)或机械通气(MV)、死亡率和HFNO脱机时间。评估呼吸指标(包括Pnose)的预测准确性。结果:入组患者中,HG组35例,LG组25例。HG患者在第7天的无rs生存期较低(调整HR=0.26, p < 0.0001),与LG患者相比,HFNO失败率较高(88%比0%,p < 0.0001),升级为NIV(84%比0%,p < 0.0001),气管插管(36%比0%,p < 0.0001)和死亡率(24%比6%,p = 0.0001)。因此,HG第28天无rs天数较低(11天比23天,p < 0.0001)。最后,在呼吸变量中,Pnose与主要结局独立相关(OR=0.64 95% CI [0.42-0.90], p = 0.02)。结论:在住院并接受HFNO治疗的AHRF患者中,Pnose是预测患者第一周内RS依赖性和生存的独立且准确的因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
European Journal of Internal Medicine
European Journal of Internal Medicine 医学-医学:内科
CiteScore
9.60
自引率
6.20%
发文量
364
审稿时长
20 days
期刊介绍: The European Journal of Internal Medicine serves as the official journal of the European Federation of Internal Medicine and is the primary scientific reference for European academic and non-academic internists. It is dedicated to advancing science and practice in internal medicine across Europe. The journal publishes original articles, editorials, reviews, internal medicine flashcards, and other relevant information in the field. Both translational medicine and clinical studies are emphasized. EJIM aspires to be a leading platform for excellent clinical studies, with a focus on enhancing the quality of healthcare in European hospitals.
期刊最新文献
Venous thromboembolism risk assessment in hospital-at-home setting: A prospective cohort study (the TROMBODOM study). Redefining "isolated" Whipple's disease: bridging the gap between clinical phenotype and pathophysiological reality. From unmet needs to new possibilities: PPAR-targeted therapies in the journey of people living with Primary Biliary Cholangitis. Heart failure and COPD - Disentangling undertreatment from the impact of severe comorbidities. Organization and delivery of home-based care for chronic obstructive pulmonary disease patients receiving long-term home non-invasive ventilation: a systematic review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1